Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $15.71, along ...

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...

Cesca Litton has completed her chemotherapy sessions months after announcing her breast cancer diagnosis. In a now-expired ...

Exactly one year on since receiving a life-changing cancer diagnosis, Fiona Price took on tied up her walking boots to ...